다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
캐나다
CSE
Revive Therapeutics Ltd (RVV)
Revive Therapeutics Ltd (RVV) 뉴스

RVV

Revive Therapeutics (RVV)

Revive Therapeutics Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:CSE:RVV

1

일자	시간	출처	헤드라인	심볼	기업
2022/04/18	23:26	InvestorsHub NewsWire	Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2022/04/12	21:00	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2022/03/29	22:57	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2022/02/14	20:53	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2022/01/17	23:13	InvestorsHub NewsWire	Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs	CSE:RVV	Revive Therapeutics Ltd
2022/01/07	22:05	InvestorsHub NewsWire	Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2021/08/18	19:00	InvestorsHub NewsWire	Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer	CSE:RVV	Revive Therapeutics Ltd
2021/08/12	22:56	InvestorsHub NewsWire	Revive Confirms No Material Undisclosed Information	CSE:RVV	Revive Therapeutics Ltd
2021/08/10	21:52	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline	CSE:RVV	Revive Therapeutics Ltd
2021/06/28	21:00	InvestorsHub NewsWire	Revive Therapeutics Approved to Trade on the OTCQB Market	CSE:RVV	Revive Therapeutics Ltd
2021/06/08	22:12	InvestorsHub NewsWire	Revive Therapeutics Partners with Supriya to Pursue EUA for Bucillamine to Treat COVID in India	CSE:RVV	Revive Therapeutics Ltd
2021/05/17	22:48	InvestorsHub NewsWire	Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip	CSE:RVV	Revive Therapeutics Ltd
2021/05/03	22:32	InvestorsHub NewsWire	Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19	CSE:RVV	Revive Therapeutics Ltd
2021/04/22	21:26	InvestorsHub NewsWire	Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional ....cont	CSE:RVV	Revive Therapeutics Ltd
2021/03/24	22:15	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2021/02/11	22:05	InvestorsHub NewsWire	Revive Therapeutics Provides Update on Cannabinoid Pharmaceuticals Program	CSE:RVV	Revive Therapeutics Ltd
2021/01/27	22:13	InvestorsHub NewsWire	Revive Therapeutics in Phase 3 clinical trial for COVID-19 treatment	CSE:RVV	Revive Therapeutics Ltd
2021/01/18	23:51	InvestorsHub NewsWire	How Combat Sports Are Researching Micro-Dosing Psychedelics To Treat Brain Injuries	CSE:RVV	Revive Therapeutics Ltd
2020/12/31	22:30	InvestorsHub NewsWire	Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study	CSE:RVV	Revive Therapeutics Ltd
2020/12/23	01:05	InvestorsHub NewsWire	Revive Therapeutics Announces LOI to Acquire PharmaTher's Psilocybin Program	CSE:RVV	Revive Therapeutics Ltd
2020/10/31	02:39	InvestorsHub NewsWire	Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2020/07/31	22:46	InvestorsHub NewsWire	Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19	CSE:RVV	Revive Therapeutics Ltd
2020/04/23	22:47	InvestorsHub NewsWire	Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial	CSE:RVV	Revive Therapeutics Ltd

검색 관련기사 보기:CSE:RVV

1

Ossiam Lmmv Ugb

Alstom SA 0.25% until 14...

HB&T Lincoln Stable Valu...

EndlessWebWorlds

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관